198835-06-2 Usage
Description
TERT-BUTYL 5-OXO-2-AZABICYCLO[2.2.1]HEPTANE-2-CARBOXYLATE is a chemical compound belonging to the azabicyclic family, characterized by its unique bicyclic structure and molecular formula C13H21NO3. It is recognized for its potential in pharmaceutical and agrochemical synthesis, as well as its intriguing properties that make it a subject of interest for scientific research and exploration.
Uses
Used in Pharmaceutical Industry:
TERT-BUTYL 5-OXO-2-AZABICYCLO[2.2.1]HEPTANE-2-CARBOXYLATE is used as a building block for the synthesis of various pharmaceuticals due to its unique structure and properties that can be leveraged in drug design and development.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, TERT-BUTYL 5-OXO-2-AZABICYCLO[2.2.1]HEPTANE-2-CARBOXYLATE serves as a key component in the creation of agrochemicals, contributing to the development of effective and novel products for agricultural applications.
Used in Scientific Research:
TERT-BUTYL 5-OXO-2-AZABICYCLO[2.2.1]HEPTANE-2-CARBOXYLATE is also used as a subject of study in scientific research for its potential pharmacological activities, with the aim of uncovering new applications and enhancing understanding of its properties and interactions.
Check Digit Verification of cas no
The CAS Registry Mumber 198835-06-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,8,8,3 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 198835-06:
(8*1)+(7*9)+(6*8)+(5*8)+(4*3)+(3*5)+(2*0)+(1*6)=192
192 % 10 = 2
So 198835-06-2 is a valid CAS Registry Number.
InChI:InChI=1S/C11H17NO3/c1-11(2,3)15-10(14)12-6-7-4-8(12)5-9(7)13/h7-8H,4-6H2,1-3H3
198835-06-2Relevant articles and documents
Synthesis and biological evaluation of pyrimidine derivatives with diverse azabicyclic ether/amine as novel GPR119 agonist
Yang, Zunhua,Fang, Yuanying,Park, Haeil
, p. 2515 - 2519 (2017/05/10)
A class of novel pyrimidine derivatives bearing diverse conformationally restricted azabicyclic ether/amine were designed, synthesized and evaluated for their GPR119 agonist activities against type 2 diabetes. Most compounds exhibited superior hEC50
TRICYCLIC GYRASE INHIBITORS
-
, (2012/09/25)
Disclosed herein are compounds having the structure of Formula I and pharmaceutically suitable salts, esters, and prodrugs thereof that are useful as antibacterially effective tricyclic gyrase inhibitors. Related pharmaceutical compositions, uses and methods of making the compounds are also contemplated.
Improved synthesis of monoprotected 5- and 6-amino-2-azanorbornanes
Dacenko, Oleksandr P.,Manoylenko, Olga V.,Grygorenko, Oleksandr O.,Mykhailiuk, Pavel K.,Volochnyuk, Dmitriy M.,Shishkin, Oleg V.,Tolmachev, Andrey A.
experimental part, p. 981 - 992 (2011/04/25)
(Chemical Equation Presented) An improved synthesis of Boc-monoprotected 5- and 6-amino-2-azanorbornanes is reported. The synthetic scheme consists of five steps and allows multigram quantities of the title compounds to be obtained. The regio- and stereochemistries of the products are established by two-dimensional NMR experiments. Copyright Taylor & Francis Group, LLC.
